Document Detail


Diagnosis of coronary artery disease with dobutamine-stress MRI.
MedLine Citation:
PMID:  15801057     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Dobutamine-stress cardiovascular magnetic resonance (CMR) is a new diagnostic tool for the non-invasive detection of coronary artery disease. Technological advances in CMR have evolved this technique to an adequate alternative to the standard cardiac stress tests. Its high reproducibility and excellent image quality of the anatomical features of the left ventricle and left ventricular function at rest and during stress make it an ideal technique for the comprehensive evaluation of patients with suspected coronary artery disease. Besides its ability to detect myocardial ischemia, CMR has proved to be diagnostic for myocardial viability as well. A recent technical refinement in CMR using myocardial tagging has improved the diagnostic accuracy for myocardial ischemia even further. Dobutamine-stress CMR is used to identify wall motion abnormalities of the left ventricle in patients with proven or suspected coronary artery disease [1-4]. Dobutamine-stress CMR has emerged as a highly accurate and safe diagnostic modality [1-4]. Recently, the use of high-dose dobutamine CMR in combination with the myocardial tagging technique has been reported, with excellent diagnostic results. The use of this new technique and the clinical applications are discussed.
Authors:
Dirkjan Kuijpers
Related Documents :
12931107 - Relationship between dobutamine response of dyssynergic myocardium and angiographically...
9396877 - Comparison of dobutamine stress echocardiography and technetium-99m sestamibi single-ph...
2786807 - Support, stress, and recovery from coronary heart disease: a longitudinal causal model.
9264417 - Impact of acute propranolol administration on dobutamine-induced myocardial ischemia as...
14517987 - Myocardial volume and organization are changed by failure of addition of secondary hear...
17646607 - Association between increased mortality and mild thyroid dysfunction in cardiac patients.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  European radiology     Volume:  15 Suppl 2     ISSN:  0938-7994     ISO Abbreviation:  Eur Radiol     Publication Date:  2005 Feb 
Date Detail:
Created Date:  2005-03-31     Completed Date:  2005-06-24     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9114774     Medline TA:  Eur Radiol     Country:  Germany    
Other Details:
Languages:  eng     Pagination:  B48-51     Citation Subset:  IM    
Affiliation:
Department of Radiology, University Medical Center Groningen, Hanzeplein 1, 9713 GZ Groningen, The Netherlands. kps@xs4all.nl
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adrenergic beta-Agonists / diagnostic use*
Coronary Disease / diagnosis*
Dobutamine / diagnostic use*
Exercise Test / methods*
Humans
Image Enhancement
Magnetic Resonance Imaging / methods*
Magnetic Resonance Imaging, Cine / methods
Myocardial Ischemia / diagnosis
Myocardium / pathology
Reproducibility of Results
Tissue Survival
Ventricular Dysfunction, Left / diagnosis
Ventricular Function, Left / physiology
Chemical
Reg. No./Substance:
0/Adrenergic beta-Agonists; 34368-04-2/Dobutamine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Role of CMR in assessment of myocardial perfusion.
Next Document:  Delayed contrast-enhanced MRI: use in myocardial viability assessment and other cardiac pathology.